Phase I Dose-Finding Trial of Letrozole in Postmenopausal Women at High Risk for Breast Cancer.
Phase of Trial: Phase I
Latest Information Update: 02 Oct 2014
At a glance
- Drugs Letrozole (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- 01 Apr 2013 Planned End Date changed from 1 Sep 2012 to 1 Sep 2014 as reported by ClinicalTrials.gov.
- 10 Sep 2012 New source identified and integrated (Mayo Clinic).
- 10 Sep 2012 Planned End Date changed from 1 Dec 2013 to 1 Sep 2012 as reported by ClinicalTrials.gov.